Navigation Links
Abaxis, Inc. to Present at Needham & Company's Eleventh Annual Growth Stock Conference
Date:12/29/2008

UNION CITY, Calif., Dec. 29 /PRNewswire-FirstCall/ -- Abaxis, Inc. (Nasdaq: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, chairman and chief executive officer will present at Needham & Company's Eleventh Annual Growth Stock Conference on Thursday, January 8, 2009 at 3:30 p.m. ET. The conference will be held at The New York Palace Hotel in New York City.

About Abaxis

Abaxis develops, manufactures and markets portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements. The system consists of a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of single-use plastic discs, called reagent discs that contain all the chemicals required to perform a panel of up to 13 tests on veterinary patients and 14 tests on human patients. The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma samples. The system provides test results in less than 12 minutes with the precision and accuracy equivalent to a clinical laboratory analyzer.

     Contact:  Clint Severson               Lytham Partners, LLC
               Chief Executive Officer      Joe Dorame, Joe Diaz & Robert Blum
               ABAXIS, Inc.                 602-889-9700
               510-675-6500

'/>"/>
SOURCE Abaxis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Abaxis, Inc. to Present at the 20th Annual Piper Jaffray Health Care Conference
2. Abaxis, Inc. to Present at CL Kings Sixth Annual Best Ideas Conference
3. Abaxis, Inc. CEO to Present at the Eighth Annual Forbes Global CEO Conference in Singapore
4. Abaxis, Inc. to Present at the Sidoti & Company Twelfth Annual New York Emerging Growth Institutional Investor Forum
5. Abaxis, Inc. to Present at the Susquehanna Financial Groups Second Annual SIGnificant Options in Healthcare Conference
6. Abaxis, Inc. to Present at the Fifth Annual Sidoti & Company Emerging Growth Conference
7. Accuray Incorporated to Present at 11th Annual Needham Growth Stock Conference
8. Stem Cells Poised to Grow Organs for Transplant : Zannos Grekos, MD Presents Clinical Data of Research with Adult Stem Cells to Physicians at International Regenerative Biomedicine Conference
9. Hot Toys May Not Be the Best Present
10. Abbott to Present at J.P. Morgan Healthcare Conference
11. Mindray Medical to Present at the 27th Annual J.P. Morgan Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...N, Nov. 9 Today,s drama...gs us one step closer to meaningful health care re...th Care for America Act makes health care more acc...y enhancing coverage, promoting preventive care an...lso serves as a sober reminder of the tremendous a...
(Date:11/9/2009)... New Health Care Reform Bill, The Afford...he House Of Representatives Saturday Night, and Is...bama by the End of the Year with Absolute Confiden...alist Certification Class Specifically for the Com...% of Americans , Hanover ...
(Date:11/9/2009)... Only 5 percent of seniors have changed ...avings, better service and improved coverage among...llment season nears , , B...ly 5 percent of seniors have changed their Medicar...y (16 percent) report they are likely to or are co...
(Date:11/9/2009)...inds that women treated for breast cancer are at h... breasts. Published in the December 15, 2009 issue...can Cancer Society, the study,s results indicate t...benefit from additional therapies following surger...e that women with dense breast tissue are at incre...
(Date:11/8/2009)...HIA, Nov. 8 The America...evention and wellness provisions in the health ref...th passage of this bill, the House takes important...tant insurance reforms and moving our health syste...e that focuses on keeping people healthy," said Ge...
Breaking Medicine News(10 mins):Health News:The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com 2Health News:The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com 3Health News:The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com 4Health News:The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com 5Health News:Few Change Medicare Plans Each Year, But Three Times as Many Are Considering a Change in 2010, Allsup Survey Finds, 2Health News:Few Change Medicare Plans Each Year, But Three Times as Many Are Considering a Change in 2010, Allsup Survey Finds, 3Health News:Few Change Medicare Plans Each Year, But Three Times as Many Are Considering a Change in 2010, Allsup Survey Finds, 4Health News:Few Change Medicare Plans Each Year, But Three Times as Many Are Considering a Change in 2010, Allsup Survey Finds, 5Health News:Breast density associated with increased risk of cancer recurrence 2Health News:APHA Applauds Prevention and Wellness Provisions in House Health Reform Bill 2
...The U-C-L-A Medical Center, in Los Angeles is witn...on after a heart transplant. His twin, also in nee...// Nick and Nate Draper, the twin brothers wer...enter. According to the Doctors, Nick Draper...
... study led by Ronald Hines, professor of pediatric...ult and children have very different drug metaboli...s (enzymes) in their body for the processing of th...e young. This plays a vital role because certa...
...ior doctor has by the means of BMJ raised a seriou...alization purposes. // This has come after n... approved and thereafter recalled after three mont... Drug Administration in 2004 on the basis of short...
...ses like diabetes, cancer and heart attack that ar...s could cause much strain to the Indian economy, /...ost by 2015, according to estimates by World Healt...s Robert Beaglehole, director of NCD, WHO. H...
...us concerns have been raised regarding the safety ...ports of increased risk of autism // in children ...st mumps, measles and rubella. Currently, ch...nt vaccine preventable diseases. The government ha...
...ed River Valley Water Supply Project's key agenda ...stern North Dakota, especially heavily populated a...ronmental groups are up in arms against this propo...eels that a task of such a magnitude , interbasin ...
Other Medicine News:
(Date:11/9/2009)...CISCO, Calif., Nov. 9 An...on November 5, 2009, it received a letter from The...he Nasdaq Hearing Panel has granted Anesiva,s requ...ket subject to the condition that Anesiva shall ha...roposed merger (the "Merger") contemplated by the ...
(Date:11/7/2009)...la., Nov. 7 Patients reported C1-e...tive therapy in treating acute swelling attacks at...etic disorder, according to data presented today a...p; Immunology (ACAAI) Annual Meeting. The results ...cted in parallel with the ongoing, prospective, op...
(Date:11/6/2009)... WASHINGTON, Pa., Nov. 6 In consul...(FDA), McNeil Consumer Healthcare, Division of McN... a limited number of product lots of TYLENOL®... distinctive red EZ-OPEN CAP. McNeil is initiating...smell or taste associated with these lots that led...
Breaking Medicine Technology:Anesiva Receives Positive Nasdaq Hearing Panel Determination for Continued Listing 2Anesiva Receives Positive Nasdaq Hearing Panel Determination for Continued Listing 3Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 3McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with EZ-OPEN CAP 2Light Sciences Oncology Expands Development of Novel Targeted Drug Aptocine 28TM 29 For Prostate Conditions With Start Up of Phase 2 BPH Trial 54732 1Light Sciences Oncology Expands Development of Novel Targeted Drug Aptocine 28TM 29 For Prostate Conditions With Start Up of Phase 2 BPH Trial 54732 2Light Sciences Oncology Expands Development of Novel Targeted Drug Aptocine 28TM 29 For Prostate Conditions With Start Up of Phase 2 BPH Trial 54732 3Abnormal Protein May Signal Pancreatic Cancer 54730 1Abnormal Protein May Signal Pancreatic Cancer 54730 2Neurimmune Therapeutics Announces Advancement of Alzheimers Program into Preclinical Development 9609 1Neurimmune Therapeutics Announces Advancement of Alzheimers Program into Preclinical Development 9609 2Neurimmune Therapeutics Announces Advancement of Alzheimers Program into Preclinical Development 9609 3
...th Lovenox(R) (enoxaparin sodium injection) were a...l within 90 days-, BRIDGEWATER, N.J., Dec 10 San... that demonstrated total hospital,direct medical c...$550 per,patient when they were treated with the u...actionated heparin (UFH) with 97.3% of LMWH patien...
... 10 Alfacell Corporation,(Nasdaq: ACEL ) today r...r,of fiscal 2008., The company recorded a net los...c and diluted common share, for the fiscal quarter...ion, or $0.05 per basic and diluted,common share, ...administrative expenses increased by approximately...
Other Medicine Technology:Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 2Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 3Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 4Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 5Alfacell Reports Financial Results for First Quarter of Fiscal 2008 2Alfacell Reports Financial Results for First Quarter of Fiscal 2008 3Alfacell Reports Financial Results for First Quarter of Fiscal 2008 4Alfacell Reports Financial Results for First Quarter of Fiscal 2008 5
Moody Curved Fixation Forceps
Lindstrom Curved Pierce Forcep
Green Fixation Forceps
Kuhnt Fixation Forceps
Medicine Products: